title: Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
abstract: Iodine deficiency is a major cause of impaired mental development, goitre, and cretinism in many parts of the world. Because existing immunization programmes can be used to deliver oral iodized oil (OIO) to infants at risk, it was important to know whether OIO could adversely affect the antibody response to vaccines, such as trivalent oral poliovirus vaccine (OPV). A randomized, double-blind, placebo-controlled clinical trial was conducted in Subang, West Java, Indonesia, in which 617 eight-week-old infants received either OIO or a placebo (poppy-seed oil) during a routine visit for their first dose of OPV as part of the Expanded Programme on Immunization (EPI). The infants received two boosters of OPV at 4-week intervals after the first dose, and were followed up when 6 months old. Neutralizing antibody titres to poliovirus serotypes 1, 2, and 3 were compared in serum samples that were taken from 478 of these infants just before the first dose of OPV and at 6 months. It was found that oral iodized oil did not reduce the antibody responses to any of the three serotypes of OPV. These results indicate that oral iodine may safely be delivered to infants at the same time as oral poliovirus vaccine according to current EPI immunization schedules.
authors.affiliation: Laboratory of Method Development, US Food and Drug Administration, Rockville, MD 20852-1448, USA.
authors.forename: R E
authors.initials: RE
authors.lastname: Taffs
authors.forename: J C
authors.initials: JC
authors.lastname: Enterline
authors.forename: K
authors.initials: K
authors.lastname: Rusmil
authors.lastname: Muhilal
authors.forename: S S
authors.initials: SS
authors.lastname: Suwardi
authors.forename: D
authors.initials: D
authors.lastname: Rustama
authors.lastname: Djatnika
authors.forename: C
authors.initials: C
authors.lastname: Cobra
authors.forename: R D
authors.initials: RD
authors.lastname: Semba
authors.forename: N
authors.initials: N
authors.lastname: Cohen
authors.forename: D M
authors.initials: DM
authors.lastname: Asher
mesh_terms: D000704:Analysis of Variance; D000914:Antibodies, Viral / Q000097:blood*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007214:Indonesia; D007223:Infant; D007455:Iodine / Q000008:administration & dosage*; D008297:Male; D009500:Neutralization Tests; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D011055:Poliovirus Vaccine, Oral; D007455:Iodine